SI

Sathyanarayana Idupulapati

Active Director Additional Director DIN 10179459
DIN 10179459 First appointment May 2023 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sathyanarayana Idupulapati

Data last updated:

Sathyanarayana Idupulapati is an Additional Director at Subesha Health Private Limited (since 2023). The company operates in Trading.

DIN 10179459
Primary Designation Additional Director
Industry Trading
First Appointment 20 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Subesha Health Private Limited U51909TG2022PTC169680
Additional Director20 May 20232022Active

Board colleagues of Sathyanarayana Idupulapati

Directorship timeline

Open interactive timeline →
Subesha Health Private Limited
Premium access

Shareholding and investment profile for Sathyanarayana Idupulapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sathyanarayana Idupulapati

Sathyanarayana Idupulapati currently holds 1 directorship: Subesha Health Private Limited (Additional Director, since 20 May 2023).

Sathyanarayana Idupulapati was first appointed on 20 May 2023 as Additional Director at Subesha Health Private Limited.

The current boards of Sathyanarayana Idupulapati's companies include Gandhi Raju Chintalapati (Subesha Health Private Limited), Rudraraju Vasundhara (Subesha Health Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available